Trending stocks today
Viemed Healthcare (VMD-T)
TSE:VMD
10.45
0.29
(2.85%) 1d
Financials
Technical Analysis
This summary was created by AI, based on 4 opinions in the last 12 months.
Viemed Healthcare (VMD-T) has seen a significant rise in its stock price over the past five years, driven by strong revenues and earnings as well as excellent performance in stock reflective of demand for healthcare tech. While concerns about the impact of diet drugs have caused some fluctuations, the company continues to hold its ground. The recent quarter's results have been positive, with beating estimates in EPS, revenue, and EBITDA, along with maintained guidance and an acquisition announcement. Cash reserves are healthy with no debt. Overall, Viemed Healthcare seems to be a strong player in the healthcare sector with potential for growth in the future.
$10.450
Unknown
Their numbers continues to soar, but shares fell last year over concerns that the hit diet drugs will impact them. But business continues to bs strong as they grow revenues and earnings. Trades at a reasonable PE.
When markets hit 52-week highs and signs point to frothiness, where do you put your money? The safe route is a savings account paying 5%. The riskier one, but could pay you more later, lies in unloved sectors. Healthcare is one. As a ventilator company, Viemed thrived during the pandemic, which explains its 174% rise in the last five years. This year has been a different story as VMD jumped to $16.25 last April, but has sunk to $11.50. (These are its TSX prices. This Louisiana-based company trades on the NYSE as well.)
(A Top Pick Jun 01/22, Up 73%)
Excellent performance in stock reflective of demand for healthcare tech.
Continues to hold.
Happy with results.
VMD EPS of 4c beat estimates of 3.5c; Revenue of $39.6M beat estimates of $38.5M. EBITDA of $8.3M beat estimates by 3%. Sales rose 23%; EPS though was flat year over year. EBITDA rose 15%. 2Q Guidance was maintained and another acquisition was announced. Cash rose to $23.5M (no debt). We would consider it a good quarter.
Unlock Premium - Try 5i Free
He didn't like it for a while, but now more than before. The telehealth space is getting crowded and they've had issues with CMS code. It's a good American company, though doesn't receive much attention here. VMS is merely okay. He prefers other names like Knight Therapeutics. It's a decent, second-tier company.
Viemed Healthcare(VMD-T) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 1
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 2
Viemed Healthcare(VMD-T) Frequently Asked Questions
What is Viemed Healthcare stock symbol?
Viemed Healthcare is a Canadian stock, trading under the symbol VMD-T on the Toronto Stock Exchange (VMD-CT). It is usually referred to as TSX:VMD or VMD-T
Is Viemed Healthcare a buy or a sell?
In the last year, 2 stock analysts published opinions about VMD-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Viemed Healthcare.
Is Viemed Healthcare a good investment or a top pick?
Viemed Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for Viemed Healthcare.
Why is Viemed Healthcare stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Viemed Healthcare worth watching?
2 stock analysts on Stockchase covered Viemed Healthcare In the last year. It is a trending stock that is worth watching.
What is Viemed Healthcare stock price?
On 2023-12-21, Viemed Healthcare (VMD-T) stock closed at a price of $10.45.
EPS of $0.04 missed estimates of $0.07 and revenues of $50.6M beat estimates of $49.9M. Revenues grew by 28% year-over-year, and its Adjusted EBITDA grew by 21%. It has no debt and management expects to generate revenues of $53.8M to $54.8M for Q2 2024. It was cash flow negative for the quarter, but its margins are good and it has a strong balance sheet. For a company growing fast with good profit margins, it is only trading at 20X forward earnings, but it is highly volatile and a small name. We consider the results overall decent, but investors are likely not pleased with its earnings miss.
Unlock Premium - Try 5i Free